ArticleCancer cell2016

T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

Ilaria Marigo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.